Vaccine targeting opioid addiction with Dr. Jay Evans

The University of Montana is a recipient of a $3.3 million dollar contract from the National Institutes of Health to develop a vaccine to treat opioid addiction.  Inimmune Corporation will be a collaborator in developing this project.  Watch the interview to...

The Future of Food Allergies – Developing New Treatments

Inimmune is developing vaccines to treat food allergies.  Read about the future prospects of treatments for food allergies here.
Inimmune Receives $1M SBIR Phase II Grant

Inimmune Receives $1M SBIR Phase II Grant

Montana biotech company receives Small Business Innovation Research Grant to develop novel treatments against infectious diseases. Inimmune Corporation, a biotechnology company located in Missoula, MT, was recently awarded $1,017,317 from the National Institute for...